FindTrial
Sign In

The Effect Evaluation of Three Types Laser Treatment for Rosacea Randomized Trial

The Effect Evaluation of Different Laser Treatment for Rosacea Randomized Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066451
Enrollment
Unknown
Registered
2022-12-06
Start date
2022-12-11
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Interventions

Group A:IPL
Group B:DPL
Group C:Elos

Sponsors

Shanghai Skin Disease Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. age from 18-70, meet 2017 international rosacea diagnosis standard 2. passed phage I drug treatment, the inflammation and skin rash was well controlled 3. looking for using laser treatment to further control the rosacea 4. signed the Informed Consent Form, and willing to corporate with the program and guideline 5. no any laser treatment during last four months

Exclusion criteria

Exclusion criteria: 1. with photo sensitization or any skin issue with laser treatment 2. pregnancy or breeding women 3. can't follow the guidelines or corporate with doctor 4. healthy consumer without diabetes, high pressure, epileptic, liver, kidney, heart diseases

Design outcomes

Primary

MeasureTime frame
EI;—

Countries

China

Contacts

Public ContactChao Yuan

Shanghai Skin Disease Hospital

dermayuan@163.com+86 18017336863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026